Sleep disordered breathing induced by cervical spinal cord injury and effect of adenosine A1 receptors modulation in rats.
Animals
Cervical Cord
/ drug effects
Cervical Vertebrae
/ drug effects
Male
Purinergic P1 Receptor Antagonists
/ pharmacology
Rats
Rats, Sprague-Dawley
Receptor, Adenosine A1
/ metabolism
Respiration
/ drug effects
Sleep
/ drug effects
Sleep Apnea Syndromes
/ drug therapy
Spinal Cord Injuries
/ drug therapy
Xanthines
/ pharmacology
DPCPX
adenosine A1 receptor blockade
cervical spinal cord hemisection
sleep-disordered breathing
spinal cord injury
Journal
Journal of applied physiology (Bethesda, Md. : 1985)
ISSN: 1522-1601
Titre abrégé: J Appl Physiol (1985)
Pays: United States
ID NLM: 8502536
Informations de publication
Date de publication:
01 12 2019
01 12 2019
Historique:
pubmed:
11
10
2019
medline:
21
10
2020
entrez:
11
10
2019
Statut:
ppublish
Résumé
Sleep-disordered breathing (SDB) is very common after spinal cord injury (SCI). The present study was designed to evaluate the therapeutic efficacy of adenosine A1 receptor blockade (8-cyclopentyl-1,3-dipropylxanthine, DPCPX) on SDB in a rodent model of SCI. We hypothesized that SCI induced via left hemisection of the second cervical segment (C2Hx) results in SDB. We further hypothesized that blockade of adenosine A1 receptors following C2Hx would reduce the severity of SDB. In the first experiment, adult male rats underwent left C2Hx or sham (laminectomy) surgery. Unrestrained whole body plethysmography (WBP) and implanted wireless electroencephalogram (EEG) were used for assessment of breathing during spontaneous sleep and for the scoring of respiratory events at the acute (~1 wk), and chronic (~6 wk) time points following C2Hx. During the second experiment, the effect of oral administration of adenosine A1 receptor antagonist (DPCPX, 3 times a day for 4 days) on SCI induced SDB was assessed. C2Hx animals exhibited a higher apnea-hypopnea index (AHI) compared with the sham group, respectively (35.5 ± 12.6 vs. 19.1 ± 2.1 events/h,
Identifiants
pubmed: 31600096
doi: 10.1152/japplphysiol.00563.2019
doi:
Substances chimiques
Purinergic P1 Receptor Antagonists
0
Receptor, Adenosine A1
0
Xanthines
0
1,3-dipropyl-8-cyclopentylxanthine
9PTP4FOI9E
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM